These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 21861141

  • 1. Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in Japan.
    Furuta T, Shimatani T, Sugimoto M, Ishihara S, Fujiwara Y, Kusano M, Koike T, Hongo M, Chiba T, Kinoshita Y, Acid-Related Symptom Research Group.
    J Gastroenterol; 2011 Nov; 46(11):1273-83. PubMed ID: 21861141
    [Abstract] [Full Text] [Related]

  • 2. Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan.
    Tominaga K, Iwakiri R, Fujimoto K, Fujiwara Y, Tanaka M, Shimoyama Y, Umegaki E, Higuchi K, Kusano M, Arakawa T, GERD 4 Study Group.
    J Gastroenterol; 2012 Mar; 47(3):284-92. PubMed ID: 22081052
    [Abstract] [Full Text] [Related]

  • 3. Clinical characteristics of elderly patients with proton pump inhibitor-refractory non-erosive reflux disease from the G-PRIDE study who responded to rikkunshito.
    Sakata Y, Tominaga K, Kato M, Takeda H, Shimoyama Y, Takeuchi T, Iwakiri R, Furuta K, Sakurai K, Odaka T, Kusunoki H, Nagahara A, Iwakiri K, Furuta T, Murakami K, Miwa H, Kinoshita Y, Haruma K, Takahashi S, Watanabe S, Higuchi K, Fujimoto K, Kusano M, Arakawa T, G-PRIDE study group.
    BMC Gastroenterol; 2014 Jul 02; 14():116. PubMed ID: 24990161
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategy.
    Miyamoto M, Manabe N, Haruma K.
    Intern Med; 2010 Jul 02; 49(15):1469-76. PubMed ID: 20686276
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy?
    Takeuchi T, Oota K, Harada S, Edogawa S, Kojima Y, Sanomura M, Sakaguchi M, Hayashi K, Hongoh Y, Itabashi T, Kitae H, Hoshimoto M, Takeuchi N, Higuchi K.
    Intern Med; 2015 Jul 02; 54(2):97-105. PubMed ID: 25742999
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Safety and efficacy of long-term maintenance therapy with oral dose of rabeprazole 10 mg once daily in Japanese patients with reflux esophagitis.
    Fujimoto K, Hongo M, Maintenance Study Group.
    Intern Med; 2011 Jul 02; 50(3):179-88. PubMed ID: 21297318
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Predicting the efficacy of proton pump inhibitors in patients with non-erosive reflux disease before therapy using dual-channel 24-h esophageal pH monitoring.
    Shimatani T, Sugimoto M, Nishino M, Adachi K, Furuta K, Ito M, Kurosawa S, Manabe N, Mannen K, Hongo M, Chiba T, Kinoshita Y, Acid-Related Symptom Research (ARS) Group.
    J Gastroenterol Hepatol; 2012 May 02; 27(5):899-906. PubMed ID: 22098590
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of hangeshashinto for treatment of GERD refractory to proton pump inhibitors : Usual dose proton pump inhibitors plus hangeshashinto versus double-dose proton pump inhibitors: randomized, multicenter open label exploratory study.
    Takeuchi T, Hongo H, Kimura T, Kojima Y, Harada S, Ota K, Takeuchi N, Noguchi T, Inoue T, Murano M, Higuchi K.
    J Gastroenterol; 2019 Nov 02; 54(11):972-983. PubMed ID: 31037449
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Symptoms and quality of life in underweight gastroesophageal reflux disease patients and therapeutic responses to proton pump inhibitors.
    Hongo M, Miwa H, Kusano M, J-FAST group.
    J Gastroenterol Hepatol; 2012 May 02; 27(5):913-8. PubMed ID: 22142515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.